The Cincinnati Herald: Local panel discusses COVID-19 impact on communities of color
UC Center for Clinical and Translational Science and Training hosts virtual discussion
The Collaboration Network hosted a virtual conference on Racial and Health Inequities Exposed by COVID-19 Thursday, November 19 from 9 a.m. to 11 a.m. Andrew Beck, MD, a Cincinnati Children’s physician and associate professor of pediatrics at the University of Cincinnati, and Karen Bankston, PhD, professor of emerita of the UC College of Nursing, were among those who discussed and presented regional data about COVID-19’s disproportionate impact on communities of color in Greater Cincinnati. The Collaboration Network is a program of the Center for Clinical & Translational Science and Training, run jointly by UC and Cincinnati Children's. The Cincinnati Herald along with other local media covered the virtual discussion.
Read the Cincinnati Herald’s coverage of the virtual meeting.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.